AU3528593A - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- AU3528593A AU3528593A AU35285/93A AU3528593A AU3528593A AU 3528593 A AU3528593 A AU 3528593A AU 35285/93 A AU35285/93 A AU 35285/93A AU 3528593 A AU3528593 A AU 3528593A AU 3528593 A AU3528593 A AU 3528593A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4209071A DE4209071A1 (en) | 1992-03-20 | 1992-03-20 | PHARMACEUTICAL PREPARATION |
DE4209071 | 1992-03-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3528593A true AU3528593A (en) | 1993-09-23 |
Family
ID=6454609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU35285/93A Abandoned AU3528593A (en) | 1992-03-20 | 1993-03-16 | Pharmaceutical composition |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0561357A1 (en) |
JP (1) | JPH0648961A (en) |
KR (1) | KR930019215A (en) |
CN (1) | CN1076357A (en) |
AU (1) | AU3528593A (en) |
CA (1) | CA2091942A1 (en) |
DE (1) | DE4209071A1 (en) |
HU (1) | HUT63764A (en) |
MX (1) | MX9301546A (en) |
NO (1) | NO931014L (en) |
PL (1) | PL298159A1 (en) |
TW (1) | TW237384B (en) |
ZA (1) | ZA931984B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5574049A (en) * | 1994-07-22 | 1996-11-12 | Sandoz Ltd. | 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3915236A1 (en) * | 1989-05-10 | 1990-11-15 | Merck Patent Gmbh | PHARMACEUTICAL PREPARATION |
DE4004268A1 (en) * | 1990-02-13 | 1991-08-14 | Merck Patent Gmbh | PHARMACEUTICAL PREPARATION |
-
1992
- 1992-03-20 DE DE4209071A patent/DE4209071A1/en not_active Withdrawn
-
1993
- 1993-03-01 CN CN93102019A patent/CN1076357A/en active Pending
- 1993-03-16 EP EP19930104284 patent/EP0561357A1/en not_active Withdrawn
- 1993-03-16 AU AU35285/93A patent/AU3528593A/en not_active Abandoned
- 1993-03-17 KR KR1019930004054A patent/KR930019215A/en not_active Application Discontinuation
- 1993-03-18 TW TW082101995A patent/TW237384B/zh active
- 1993-03-18 CA CA002091942A patent/CA2091942A1/en not_active Abandoned
- 1993-03-19 ZA ZA931984A patent/ZA931984B/en unknown
- 1993-03-19 MX MX9301546A patent/MX9301546A/en unknown
- 1993-03-19 NO NO93931014A patent/NO931014L/en unknown
- 1993-03-19 PL PL29815993A patent/PL298159A1/en unknown
- 1993-03-19 JP JP5098990A patent/JPH0648961A/en active Pending
- 1993-03-19 HU HU9300796A patent/HUT63764A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL298159A1 (en) | 1993-10-18 |
EP0561357A1 (en) | 1993-09-22 |
HUT63764A (en) | 1993-10-28 |
NO931014D0 (en) | 1993-03-19 |
NO931014L (en) | 1993-09-21 |
CA2091942A1 (en) | 1993-09-21 |
DE4209071A1 (en) | 1993-09-23 |
KR930019215A (en) | 1993-10-18 |
MX9301546A (en) | 1993-09-01 |
ZA931984B (en) | 1993-10-19 |
CN1076357A (en) | 1993-09-22 |
JPH0648961A (en) | 1994-02-22 |
HU9300796D0 (en) | 1993-06-28 |
TW237384B (en) | 1995-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5681294A (en) | Tastemasked pharmaceutical materials | |
AU3716193A (en) | Pharmaceutical compositions | |
GB9319500D0 (en) | Pharmaceutical composition | |
AU5100393A (en) | Diindolo compounds and pharmaceutical compositions containing them | |
GB9316580D0 (en) | Pharmaceutical composition | |
GB2272375B (en) | Pharmaceutical composition | |
AU3542993A (en) | Pharmaceutical compounds | |
AU2531295A (en) | Pharmaceutical composition | |
AU2392492A (en) | Pharmaceutical composition | |
CA2100836A1 (en) | Pharmaceutical Composition | |
ZA937592B (en) | Pharmaceutical composition | |
AU5294393A (en) | Topical pharmaceutical compositions | |
ZA94155B (en) | Pharmaceutical composition | |
ZA935078B (en) | Pharmaceutical composition | |
AU2537992A (en) | Pharmaceutical compositions | |
RU2003257C1 (en) | Phytotea composition | |
AU3528593A (en) | Pharmaceutical composition | |
AU7135091A (en) | Pharmaceutical composition | |
ZA935931B (en) | Pharmaceutical composition | |
ZA924061B (en) | Pharmaceutical composition | |
AU673835C (en) | Medicinal composition comprising TCF-II | |
AUPM303393A0 (en) | Pharmaceutical composition | |
GB9206046D0 (en) | Pharmaceutical composition | |
GB9215976D0 (en) | Pharmaceutical composition | |
GB9221003D0 (en) | Pharmaceutical composition |